ID: ALA4535071

Max Phase: Preclinical

Molecular Formula: C19H17N3O2S2

Molecular Weight: 383.50

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)Nc1sc(C(=O)c2ccc(-c3cccc(O)c3)s2)c(N)c1C#N

Standard InChI:  InChI=1S/C19H17N3O2S2/c1-10(2)22-19-13(9-20)16(21)18(26-19)17(24)15-7-6-14(25-15)11-4-3-5-12(23)8-11/h3-8,10,22-23H,21H2,1-2H3

Standard InChI Key:  DVOCKTBGYBUOJB-UHFFFAOYSA-N

Associated Targets(Human)

Maternal embryonic leucine zipper kinase 3491 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 383.50Molecular Weight (Monoisotopic): 383.0762AlogP: 4.69#Rotatable Bonds: 5
Polar Surface Area: 99.14Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.03CX Basic pKa: CX LogP: 4.69CX LogD: 4.68
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.56Np Likeness Score: -0.92

References

1. Boutard N, Sabiniarz A, Czerwińska K, Jarosz M, Cierpich A, Kolasińska E, Wiklik K, Gluza K, Commandeur C, Buda A, Stasiowska A, Bobowska A, Galek M, Fabritius CH, Bugaj M, Palacz E, Mazan A, Zarębski A, Krawczyńska K, Żurawska M, Zawadzki P, Milik M, Węgrzyn P, Dobrzańska M, Brzózka K, Kowalczyk P..  (2019)  5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors.,  29  (4): [PMID:30626559] [10.1016/j.bmcl.2018.12.051]

Source